Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
40.76
+2.51 (6.56%)
Nov 22, 2024, 1:58 PM EST - Market open
Moderna Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Moderna stock have an average target of 83, with a low estimate of 40 and a high estimate of 139. The average target predicts an increase of 103.63% from the current stock price of 40.76.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock from 17 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 2 | 2 | 3 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 8 | 8 | 7 | 10 | 11 | 10 |
| Sell | 2 | 2 | 0 | 1 | 1 | 2 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 14 | 15 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $115 → $69 | Buy | Reiterates | $115 → $69 | +69.28% | Nov 18, 2024 |
| HSBC | HSBC | Hold → Strong Buy Upgrades $58 | Hold → Strong Buy | Upgrades | $58 | +42.30% | Nov 18, 2024 |
| Wolfe Research | Wolfe Research | Sell Initiates $40 | Sell | Initiates | $40 | -1.86% | Nov 15, 2024 |
| Barclays | Barclays | Buy Maintains $125 → $111 | Buy | Maintains | $125 → $111 | +172.33% | Nov 8, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 8, 2024 |
Financial Forecast
Revenue This Year
3.33B
from 6.85B
Decreased by -51.36%
Revenue Next Year
3.18B
from 3.33B
Decreased by -4.53%
EPS This Year
-9.60
from -12.34
EPS Next Year
-8.85
from -9.60
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.8B | 4.4B | 6.3B | ||
| Avg | 3.3B | 3.2B | 4.2B | ||
| Low | 2.7B | 2.4B | 2.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -44.0% | 32.3% | 97.5% | ||
| Avg | -51.4% | -4.5% | 30.8% | ||
| Low | -60.2% | -29.1% | -15.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.56 | -6.25 | -1.12 | ||
| Avg | -9.60 | -8.85 | -6.39 | ||
| Low | -10.87 | -9.78 | -8.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.